Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Nuoyuan Medical Devices is a high-tech medical technology company specializing in the development and manufacturing of advanced optical molecular imaging and surgical navigation systems. Founded in 2015, the company focuses on real-time fluorescence imaging technology, particularly utilizing indocyanine green (ICG) to assist surgeons in identifying anatomical structures and assessing tissue perfusion. Their flagship NuoVision series provides high-definition, multi-spectral imaging for various surgical specialties, including oncology, hepatobiliary, and reconstructive surgery. By integrating precision optics with intelligent software, Nuoyuan aims to improve surgical outcomes and minimize intraoperative risks. The company is a leader in the Chinese domestic market for fluorescence-guided surgery and continues to expand its portfolio into minimally invasive endoscopic systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Nuoyuan Medical Devices.